<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Recently, remdesivir was recognized as a promising antiviral drug against a large array of RNA viruses. This is equivalent to adenosine, which integrates into the chains of embryonic viral RNA and results in premature termination. Warren et al. demonstrated that the non-human primate model’s intravenous administration of 10 mg/kg of remdesivir resulted in concomitant persistent levels of its active form in the blood (10 μM) and offered 100% protection against the most feared Ebola virus infection (Warren et al. 
 <xref ref-type="bibr" rid="CR17">2016</xref>).
</p>
